期刊
MOVEMENT DISORDERS
卷 30, 期 2, 页码 150-159出版社
WILEY
DOI: 10.1002/mds.26099
关键词
Parkinson's; Impulse control; Management; Dopamine Agonist Withdrawal; Deep Brain Stimulation; Clinical Trials
资金
- Movement Disorders Society (USA)
- National Institute of Health (USA) [U13NS080495]
- Parkinson's Disease Foundation (USA)
- Parkinson's UK
- Parkinson's Disease Society (Canada)
- AbbVie Ltd
- UCB
- St Jude Medical Limited
Impulse control disorders in Parkinson's disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies, including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, nonpharmacological treatments (such as cognitive behavioral therapy and deep brain stimulation), and other as yet experimental strategies. (c) 2015 International Parkinson and Movement Disorder Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据